The global bronchitis treatment market is growing at a significant CAGR of around 3.4% during the forecast period (2020-2026). Bronchitis is referred to the inflammation of the lining in bronchial tube, one that carries air to lungs. There are two types of bronchitis, namely, acute bronchitis and chronic bronchitis. The acute bronchitis is common, whereas, chronic bronchitis is indicated to a serious condition of bronchitis. The treatment of bronchitis involves oxygen therapy and medications. The bronchitis treatment market includes revenue generated by both treatment types, oxygen therapy and drugs. The major factors that are responsible for driving the global market growth includes the rising geriatric population and sedentary lifestyle, including the excessive smoking. According to WHO, smoking is the leading cause of mortalities responsible for around 7 million fatalities across the globe. Smoke caused by tobacco generates tar in the lungs, resulting in coughs, colds, wheezing, lung cancer and asthma. As per WHO, about 235 million people have asthma globally. Such rising prevalence of asthma and chronic obstructive pulmonary disease (COPD) is offering growth to the bronchitis treatment market.

Free Sample Copy @ https://www.omrglobal.com/request-sample/bronchitis-treatment-market

The global bronchitis treatment market is classified on the basis of geography, which includes North America, Europe, Asia-Pacific, and Rest of the World. North America holds a significant share in the global bronchitis treatment market. The US plays the critical role in geographic contribution of North America in global bronchitis treatment market, attributing to the well-developed healthcare infrastructure and insurance policies. The rising prevalence of asthma and COPD is further augmenting the market growth in the region. COPD is the third leading cause of mortality in the US.

Moreover, the presence of key market players, such as Abbott Laboratories and Teva Pharmaceutical Industries Ltd. is augmenting the market growth in North America. Canada government spends significant money in improving the healthcare system and providing medical support to the citizens. According to the CDC, each year over 2 million people are living with asthma in Canada that contributes to about 350 deaths annually. Asthma rates have increased in Canada over the last 20 years. This, in turn, is increasing the treatment of bronchitis.

A Full Report of Global Bronchitis Treatment Market is Available at:
https://www.omrglobal.com/industry-reports/bronchitis-treatment-market

Moreover, the rising industrialization is increasing the air pollution across the globe. Significant rise in air pollution is one of the major causes of lung diseases. As per WHO, 9 out of 10 people globally breathe polluted air and 7 million mortalities occurred every year due to exposure to fine particles in polluted air. There are several studies based on the analysis of the effect of air pollutants on the bronchitis diseases. Based on these studies, there is relatively a higher prevalence of symptoms of bronchitis in areas with higher particulate air pollution. Moreover, the outbreak of COVID-19 pandemic is expected to augment the global bronchitis treatment market growth during the forecast period. However, patent expiry of drugs is one among the major factors that will hinder the market growth during the forecast period.

Global Bronchitis Treatment Market – Segmentation
by Type
Drugs
Antibiotics
Anti-inflammatory drugs
Bronchodilators
Others (Mucolytics)
Oxygen Therapy

Global Bronchitis Treatment Market – Segmentation by Region 
North America 
United States
Canada
Europe
Germany
United Kingdom
France
Spain
Italy
Rest of Europe
Asia-Pacific 
China
Japan
India
Rest of Asia-Pacific
Rest of the World

Company Profiles
Abbott Laboratories
Aurobindo Pharma Ltd.
Bayer AG
Boehringer Ingelheim International GmbH
Cipla Ltd.
Dr Reddy's Laboratories Ltd.
GlaxoSmithKline PLC
Lupin Pharmaceuticals, Inc.
Mayne Pharma Group Ltd.
Merck & Co., Inc.
Mucinex (Reckitt Benckiser Group plc)
Novartis AG
Pfizer Inc.
Sanofi SA
Teva Pharmaceutical Industries Ltd.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/bronchitis-treatment-market

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

Media Contact:

Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [email protected] 
Contact no: +91 780-304-0404